DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

DIGITAL CONTENT

4 NEWS #PharmaBuzz

media
4 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ibmx, 28822-58-4, Isobutylmethylxanthine, 1-methyl-3-isobutylxanthine, Methylisobutylxanthine, 3-isobutyl-1-methylxanthine (ibmx)

Molecular Formula

C₁₀H₁₄N₄O₂

Molecular Weight

222.24 g/mol

InChI Key

APIXJSLKIYYUKG-UHFFFAOYSA-N

FDA UNII

TBT296U68M

A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES

1 2D Structure

Isobutylmethylxanthine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione

2.1.2 InChI

InChI=1S/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12)

2.1.3 InChI Key

APIXJSLKIYYUKG-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)CN1C2=C(C(=O)N(C1=O)C)NC=N2

2.2 Other Identifiers

2.2.1 UNII

TBT296U68M

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1 Methyl 3 Isobutylxanthine

2. 1-methyl-3-isobutylxanthine

3. 3 Isobutyl 1 Methylxanthine

4. Ibmx

5. Isobutyltheophylline

2.3.2 Depositor-Supplied Synonyms

1. Ibmx

2. 28822-58-4

3. Isobutylmethylxanthine

4. 1-methyl-3-isobutylxanthine

5. Methylisobutylxanthine

6. 3-isobutyl-1-methylxanthine (ibmx)

7. 1h-purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-

8. Xanthine, 3-isobutyl-1-methyl-

9. 3-isobutyl-1-methyl-1h-purine-2,6(3h,7h)-dione

10. 3-isobutyl-1-methyxanthine

11. 1-methyl-3-(2-methylpropyl)-7h-purine-2,6-dione

12. 3-isobutyl-1-methyl-3,9-dihydro-1h-purine-2,6-dione

13. 3-isobutyl-1-methyl-7h-xanthine

14. 3,7-dihydro-3-isobutyl-1-methyl-1h-purine-2,6-dione

15. Nsc 165960

16. Chebi:34795

17. C10h14n4o2

18. 3-isobutyl-1-methyl-3,7-dihydro-1h-purine-2,6-dione

19. 2-acetoxy-benzoic Acid

20. 3-isobutyl-methylxanthine

21. Nsc165960

22. 1-methyl-3-(2-methylpropyl)-3,7-dihydro-1h-purine-2,6-dione

23. 3-isobutyl-1-methyl-xanthine

24. Chembl275084

25. Tbt296u68m

26. Nsc-165960

27. Sc 2964

28. 1-methyl-3-(2-methylpropyl)-3,9-dihydro-1h-purine-2,6-dione

29. 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-2,6-dione

30. Methyl-isobutylxanthine

31. 3-isobutyl 1-methylxanthine

32. Smr000326697

33. Ccris 4290

34. Sr-01000075185

35. Einecs 249-259-3

36. Mfcd00005584

37. Unii-tbt296u68m

38. 1zkl

39. 1zkn

40. 3ecn

41. 3itu

42. 3jwr

43. 2hd1

44. 2r8q

45. 3qi4

46. Spectrum2_001705

47. Spectrum2_001735

48. Spectrum3_001958

49. Spectrum4_001052

50. Spectrum5_001856

51. Lopac-i-5879

52. Molmap_000030

53. 3-isobutyl-1-methylanxthine

54. Lopac0_000642

55. Oprea1_135287

56. Oprea1_228781

57. Schembl50315

58. 3-isobutyl-1-methylxantliine

59. Bspbio_001153

60. Bspbio_003558

61. Gtpl388

62. Kbiogr_000493

63. Kbiogr_001344

64. Kbiogr_002566

65. Kbioss_000493

66. Kbioss_002575

67. 1-methyl-3-isobutyl-xanthine

68. Mls001056732

69. Mls001066424

70. Divk1c_000922

71. Spectrum1505298

72. Spectrum2300204

73. Spbio_001690

74. Spbio_001810

75. Dtxsid0040549

76. Bcbcmap01_000110

77. Bdbm15336

78. Chebi:43253

79. Hms502o04

80. Kbio1_000922

81. Kbio2_000493

82. Kbio2_002566

83. Kbio2_003061

84. Kbio2_005134

85. Kbio2_005629

86. Kbio2_007702

87. Kbio3_000905

88. Kbio3_000906

89. Kbio3_002878

90. Kbio3_003044

91. 3-isobutyl-1-methyl-9h-xanthine

92. Cmap_000087

93. Ninds_000922

94. 1-methyl-3-(2-methylpropyl)-1,3,7-trihydropurine-2,6-dione

95. Bio1_000456

96. Bio1_000945

97. Bio1_001434

98. Bio2_000407

99. Bio2_000887

100. Hms1362i15

101. Hms1792i15

102. Hms1990i15

103. Hms2090j10

104. Hms2231c11

105. Hms3262a05

106. Hms3369e16

107. Hms3403i15

108. Hms3604d14

109. Hms3648o18

110. Albb-024315

111. Bcp13248

112. Zinc3861807

113. Tox21_500642

114. 3-isobuthyl-1-methylxanthine

115. Bdbm50027176

116. Ccg-39513

117. Ccg-39624

118. Hsci1_000261

119. Pdsp1_000324

120. Pdsp2_000322

121. S5836

122. Stl558248

123. Akos003390599

124. Akos015903085

125. Cs-3361

126. Db07954

127. Lp00642

128. Sc-2964

129. Sdccgsbi-0050622.p003

130. Idi1_000922

131. Idi1_002162

132. Ncgc00015559-01

133. Ncgc00015559-02

134. Ncgc00015559-03

135. Ncgc00015559-04

136. Ncgc00015559-05

137. Ncgc00015559-06

138. Ncgc00015559-07

139. Ncgc00015559-08

140. Ncgc00015559-09

141. Ncgc00015559-10

142. Ncgc00015559-11

143. Ncgc00015559-21

144. Ncgc00094009-01

145. Ncgc00094009-02

146. Ncgc00094009-03

147. Ncgc00094009-04

148. Ncgc00094009-05

149. Ncgc00094009-06

150. Ncgc00261327-01

151. Xanthine, 1-methyl-3-(2-methylpropyl)

152. As-71134

153. Bi164529

154. Hy-12318

155. Ibmx(nsc165960; Sc2964)

156. 3-isobutyl-1-methyl-7h-purine-2,6-dione

157. Db-047466

158. [eur J Pharmacol 170: 35 (1989)]

159. B7206

160. Eu-0100642

161. Ft-0615920

162. Wln: T56 Bm Dn Fnvnvj F1y1&1 H1

163. D71221

164. I 5879

165. 3-isobutyl-1-methylxanthine, Bioultra, >=99%

166. 822i584

167. A876607

168. L001156

169. Q223093

170. 3-isobutyl-1-methylxanthine - Cas 28822-58-4

171. J-640140

172. J-800144

173. Sr-01000075185-1

174. Sr-01000075185-6

175. 3-isobutyl-1-methylxanthine, >=99% (hplc), Powder

176. Brd-k94979336-001-06-9

177. Brd-k94979336-001-09-3

178. 1h-purine-2, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-

179. Imx;isobutylmethylxanthine;methylisobutylxanthine;nsc165960;sc2964

180. 1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1h-purine-2,6-dione

181. 1-methyl-3-(2-methylpropyl)-2,3,6,9-tetrahydro-1h-purine-2,6-dione

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₁₄N₄O₂
Molecular Weight	222.24 g/mol
XLogP3	1.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Exact Mass	222.11167570 g/mol
Monoisotopic Mass	222.11167570 g/mol
Topological Polar Surface Area	69.3 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	318
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Phosphodiesterase Inhibitors

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)

API SUPPLIERS